Dean J Mitchell's Net Worth
$7.72 Million
Who is Dean J Mitchell?
Dean J Mitchell has an estimated net worth of $7.72 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, Talecris Biotherapeutics Holdings Corp., ImmunoGen, Inc., Praxis Precision Medicines, Inc., Theravance Biopharma, Inc., PRECIGEN, INC., Kinnate Biopharma Inc., ISTA PHARMACEUTICALS INC, GUILFORD PHARMACEUTICALS INC, MGI PHARMA INC, and ALPHARMA INC.
SEC CIK
Dean J Mitchell's CIK is 0001199297
Past Insider Trading and Trends
2008 was Dean J Mitchell's most active year for acquiring shares with 30 total transactions. Dean J Mitchell's most active month to acquire stocks was the month of February. 2005 was Dean J Mitchell's most active year for disposing of shares, totalling 48 transactions. Dean J Mitchell's most active month to dispose stocks was the month of September. 2004 saw Dean J Mitchell paying a total of $3,690,525.00 for 632,500 shares, this is the most they've acquired in one year. In 2008 Dean J Mitchell cashed out on 540,315.679 shares for a total of $18,969,275.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.6
President, U.S. Primary Care
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.00% | 10K |
—
|
—
| 60K |
Sep 10
| |||
No matching records found |
Talecris Biotherapeutics Holdings Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.02K |
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 3.02K |
—
|
—
| 3.02K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ImmunoGen, Inc. (IMGN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -103.00K |
—
|
—
|
0
|
Feb 12
| |||
Form 4/A
| +10.75% | 10K |
$14.70 | $147,000.00 | 103K |
Sep 22
| |||
Form 4
| +7.01% | 10K |
$14.70 | $147,000.00 | 152.67K |
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
| +830.00% | 83K |
$3.87 | $321,400.00 | 93K |
Sep 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
∞
| 10K |
$12.51 | $125,110.00 | 10K |
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Praxis Precision Medicines, Inc. (PRAX) Snapshot price: $54.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +200.00% | 50K |
$0.84 | $41,815.00 | 75K |
Mar 24
| |||
Form 4
|
∞
| 25K |
$1.81 | $45,187.50 | 25K |
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.05% | 10.54K |
—
|
—
| 80.56K |
May 8
| |||
Form 4
| +15.00% | 9.13K |
—
|
—
| 70.02K |
May 2
| |||
Form 4
| +19.30% | 9.85K |
—
|
—
| 60.89K |
Apr 26
| |||
Form 4
| +23.85% | 9.83K |
—
|
—
| 51.03K |
Apr 27
| |||
Form 4
| +19.19% | 6.63K |
—
|
—
| 41.21K |
Apr 28
| |||
Form 4
| +32.02% | 8.38K |
—
|
—
| 34.57K |
Apr 30
| |||
Form 4
| +45.48% | 8.19K |
—
|
—
| 26.19K |
May 1
| |||
Form 4
| +50.00% | 6K |
—
|
—
| 18K |
May 17
| |||
Form 4
| +100.00% | 6K |
—
|
—
| 12K |
May 3
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Apr 22
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |